doi: 10.1055/s-2007-981457 86 FortunatoRSFerreiraACHechtFDupuyCCarvalhoDP
Longer term For longer protocols, review metabolic, IGF-1, kidney, liver, and cardiovascular trends every 3 months with a clinician
Salvati KA, Ritger ML, Davoudian PA, ODell F, Wyskiel DR, Souza GM, et al
Estimates suggest oral bioavailability for peptides like BPC-157 may be only 1-2%, meaning massive doses would be required to achieve systemic effects
Whether pulsatile is meaningfully better than sustained at wellness doses isnt settled by head-to-head trials, but the mechanistic argument is the reason we choose no-DAC
Research Documentation Context Supports compound characterization in controlled laboratory settings